Genotyping Assay Market: Growth Patterns and Forecast

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Genotyping Assay Market Compare Between 2026 And 2030?

The genotyping assay market size has experienced significant growth in recent years. It is anticipated to expand from $41.31 billion in 2025 to $50.86 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.1%. The increase observed during the historic period is linked to the development of pcr techniques, the expansion of molecular diagnostics, the necessity for pharmaceutical safety testing, early assay commercialization efforts, and demand from academic research.

The genotyping assay market is poised for significant expansion in the coming years. Projections indicate it will reach $116.09 billion by 2030, driven by a compound annual growth rate (CAGR) of 22.9%. This anticipated growth during the forecast period is fueled by several factors, including the surge in biomarker-driven drug development, enhanced automation within laboratories, the broadening scope of companion diagnostics, a growing need for rapid assays, and stringent regulatory validation. Key trends expected over the forecast horizon encompass a heightened demand for SNP-based assays, the greater integration of PCR-based genotyping, the emergence of high-sensitivity genotyping assays, the wider application of genotyping assays in drug development, and the incorporation of automation into assay processing.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

What Key Factors Are Shaping The Genotyping Assay Market Landscape?

The rising occurrence of genetic disorders is anticipated to fuel the expansion of the genotyping assay market in the future. These conditions are medical ailments resulting from irregularities or changes in a person’s deoxyribonucleic acid (DNA). Genotyping assays work by comparing the DNA of those affected with healthy individuals to identify alterations, thereby pinpointing specific genetic mutations or variations associated with a certain genetic disorder. For example, in June 2023, Gene People, a registered charity in the UK dedicated to aiding individuals with genetic conditions, disclosed that genetic disorders affected one in every 25 children in the UK, impacting around 30,000 newborns and young children and over 2.4 million children and adults each year. Consequently, the growing incidence of genetic disorders is propelling the development of the genotyping assay market.

Which Segment Classifications Are Used In The Genotyping Assay Market Segment Analysis?

The genotyping assay market covered in this report is segmented –

1) By Product And Service: Reagents And Kits, Genotyping Services, Instruments, Bioinformatics

2) By Technology: Microarrays, Polymerase Chain Reaction, Sequencing, Capillary Electrophoresis, Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry, Other Technologies

3) By End-User: Pharmacogenomics, Personalized Medicine And Diagnostics, Animal Genetics, Agricultural Biotechnology, Research And Diagnostic Laboratories, Academic Institutes

Subsegments:

1) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits

2) By Genotyping Services: Genotyping by PCR, Whole Genome Sequencing Services, SNP Genotyping Services

3) By Instruments: PCR Machines, Sequencing Instruments, Microarrays

4) By Bioinformatics: Data Analysis Software, Genotyping Data Management Tools

What Market Trends Are Affecting The Genotyping Assay Market?

Leading companies in the genotyping assay market are advancing genomic research, including the development of CE-IVD marked assays to identify treatment-resistant strains of HIV-1. The CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit is a Sanger sequencing-based assay designed to analyze positive human immunodeficiency virus (HIV) samples, detecting genetic variants that may confer resistance to common antiretroviral therapies. For instance, in January 2023, Thermo Fisher Scientific, a US-based firm, launched this CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit. This system is effective in identifying treatment-resistant HIV-1 strains and features genomic mutation assessment, utilization of HIV RNA, detection of drug resistance mutations, reliance on gold-standard Sanger sequencing technology, and suitability for clinical applications. The introduction of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit offers significant benefits by enhancing the detection of treatment-resistant HIV-1 strains, providing convenient ready-to-use reagents and controls, fulfilling regulatory requirements, demonstrating high-performance characteristics, and ensuring compatibility with existing sequencing platforms and workflows.

Which Firms Are Contributing To The Genotyping Assay Market Ecosystem?

Major companies operating in the genotyping assay market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies plc, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs

Get The Full Genotyping Assay Market Report:

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Which Region Is The Top Contributor To The Genotyping Assay Market By Share?

North America was the largest region in the genotyping assay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Genotyping Assay Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Browse Through More Reports Similar to the Global Genotyping Assay Market 2026, By The Business Research Company

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Genotyping Market Report 2026

https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

Reporter Gene Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/reporter-gene-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795